Salsalate

双水杨酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSalsalate
Drug Alias NameSalsalatum双水杨酯Salsalato双方杨酯水杨酰水杨酸 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainOverweightInflammation +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of IowaUniversity Of MichiganUniversity Of Illinois At Chicago +[5] 
Inactive CompaniesThe Brigham and Women's HospitalIndiana UniversityJoslin Diabetes Center Inc +[5] 
Active IndicationsPainInflammationDiabetes Mellitus, Type 1 +[9] 
Inactive IndicationsOverweightObesityInsulin Resistance +[7] 

Other Information

ATC CodeN02BA06
Related LinksWikipediaDrugBankKEGG